METHOD FOR PREDICTING INDIVIDUAL TUMOR SENSITIVITY TO CHEMOTHERAPY

medicine. SUBSTANCE: method involves applying biochemical examination and chemotherapy. Before beginning the treatment, melatonin epiphysis hormone availability in urine is to be determined in patients suffering from local mammary gland carcinoma. The value being found within the limits of 6.4-11.2...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VLADIMIROVA L.JU, KUCHEROVA T.I, SIDORENKO JU.S, VERKHOVTSEVA A.I, VLADIMIROVA A.N, MAKSIMOVA N.A, ARZAMASTSEVA M.A, KOZLOVA M.B
Format:	Patent
Sprache:	eng
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	medicine. SUBSTANCE: method involves applying biochemical examination and chemotherapy. Before beginning the treatment, melatonin epiphysis hormone availability in urine is to be determined in patients suffering from local mammary gland carcinoma. The value being found within the limits of 6.4-11.2 nmole/day high tumor sensitivity to chemotherapy is considered to be the case. The value being beyond the inferior norm boundary, tumor sensitivity to chemotherapy is considered to be insufficient for the selected therapy method. EFFECT: enhanced effectiveness and simplicity of method. 4 dwg